BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2026 9:40:30 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-03-19 00:41 |
|
Peer-Review Started |
|
2026-03-19 00:42 |
|
First Decision by Editorial Office Director |
|
2026-04-04 02:12 |
|
Return for Revision |
|
2026-04-04 02:12 |
|
Revised |
|
2026-04-08 00:25 |
|
Publication Fee Transferred |
|
2026-04-14 13:39 |
|
Second Decision by Editor |
|
2026-04-22 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-22 06:00 |
|
Articles in Press |
|
2026-04-22 06:00 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-17 07:11 |
|
Publish the Manuscript Online |
|
2026-07-13 09:40 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Prognostic value of pan-immune-inflammation index in hepatocellular carcinoma compared with albumin-bilirubin and model for end-stage liver disease sodium
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Salih Karatlı, Doğan Yazılıtaş, Seher Kaya, Gökşen İ İmamoğlu, Selahattin Çelik and Galip C Uyar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salih Karatlı, MD, Department of Medical Oncology, Ankara Etlik City Hospital, Varlık Neighborhood, Halil Sezai Erkut Avenue, Yenimahalle, Ankara 06000, Türkiye. karatlisalih@hotmail.com |
| Key Words |
Hepatocellular carcinoma; Pan-immune-inflammation value; Systemic inflammation; Prognostic biomarkers; Albumin-bilirubin score; Model for end-stage liver disease-sodium score; Survival; Prognosis |
| Core Tip |
Pan-immune-inflammation value (PIV) is a novel biomarker reflecting systemic inflammatory and immune status in hepatocellular carcinoma (HCC). In this retrospective study, PIV demonstrated superior prognostic performance compared with conventional liver function scores such as albumin-bilirubin and model for end-stage liver disease-sodium and remained an independent predictor of overall survival. These findings suggest that inflammation-based indices may improve risk stratification beyond traditional liver function-based models in patients with HCC. |
| Publish Date |
2026-07-13 09:40 |
| Citation |
Karatlı S, Yazılıtaş D, Kaya S, İmamoğlu Gİ, Çelik S, Uyar GC. Prognostic value of pan-immune-inflammation index in hepatocellular carcinoma compared with albumin-bilirubin and model for end-stage liver disease sodium. World J Gastrointest Oncol 2026; 18(7): 121250
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i7/121250.htm |
| DOI |
https://doi.org/10.4251/wjgo.v18.i7.121250 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
